Press release
Premature Labor (Tocolysis) - Pipeline Review, H2 2017
Premature Labor (Tocolysis) - Pipeline Review, H2 2017
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Premature Labor (Tocolysis) - Pipeline Review, H2 2017, provides an overview of the Premature Labor (Tocolysis) (Women's Health) pipeline landscape.
Preterm labor or premature labor is defined as labor that begins before completion of 36 weeks of pregnancy. Symptoms include sensation of pelvic or lower abdominal pressure, mild abdominal cramps, diarrhea, vaginal spotting or bleeding and constant low, dull backache. Treatment includes corticosteroids and tocolytics.
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Premature Labor (Tocolysis) - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Premature Labor (Tocolysis) (Women's Health), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Premature Labor (Tocolysis) (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Premature Labor (Tocolysis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I and Preclinical stages are 1, 1, 2, 1 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 2 molecules, respectively.
Premature Labor (Tocolysis) (Women's Health) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
To Enquire about this Report please visit @ https://www.reportsworldwide.com/enquiry?report_id=41762
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Premature Labor (Tocolysis) (Women's Health).
- The pipeline guide reviews pipeline therapeutics for Premature Labor (Tocolysis) (Women's Health) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Premature Labor (Tocolysis) (Women's Health) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Premature Labor (Tocolysis) (Women's Health) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Premature Labor (Tocolysis) (Women's Health)
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Premature Labor (Tocolysis) (Women's Health).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Premature Labor (Tocolysis) (Women's Health) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
To view a detailed description and Table of Contents please visit: https://www.reportsworldwide.com/report/premature-labor-tocolysis-pipeline-review-h2-2017
ReportsWorldwide.com is a leading provider of global market intelligence reports and services. With research reports from top publishers, consulting and advisory firms, ReportsWorldwide.com offers instant online access to a growing database of expert insights on global industries, companies, products, geographies and trends.
Press Contact:
Abigail Crasto
Senior Vice President
101, Arch Street
Boston, MA 02110
US
Phone +1 (617) 398-4994
Fax +1 (617) 398-4995
abigail@reportsworldwide.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Premature Labor (Tocolysis) - Pipeline Review, H2 2017 here
News-ID: 791462 • Views: …
More Releases from ReportsWorldwide
World Deep Brain Stimulation Market Top Segments, Key Players Revenue, Growth Ra …
The World Deep Brain Stimulation Market is estimated to represent a global market of USD 751.8 million by 2017 with growth rate of 18.2%. Deep brain stimulation (DBS) procedure is primarily used for the treatment of neuropsychiatric disorders such as mood disorder, dementia, anxiety and others. The procedure involve the use of neurotransmitter (brain pacemaker) that enables to transmit electric impulses to the specific target of brain cells. Increasing incidence…
New report explores the Gene Editing Market : Ushering The Next Breakthrough in …
Boston, MA
ReportsWorldwide has announced the addition of a new report title Gene Editing The Next Breakthrough in Regenerative Medicine to its growing collection of premium market research reports.
Genome editing is a type of genetic engineering in which DNA is replaced, inserted or deleted in a living organism's ggenome using engineered molecular scissors.
Believed to be one of the great biotechnology breakthroughs, gene editing is a powerful tool in pharmaceutical research that…
Global In-Building Wireless BTSController-based Small Cells Market Analysis and …
Boston, MA
ReportsWorldwide has announced the addition of a new report title Global In-Building Wireless BTSController-based Small Cells Market Analysis and Forecast, 2017-2021 to its growing collection of premium market research reports.
This report covers the leading in-building wireless enterprise BTS/controller-based small cells network equipment manufacturers:
• CommScope/Airvana
• Comba Telecom
• Ericsson
• Huawei Technologies
• Nokia
• SpiderCloud
• ZTE Corporation
This report covers the global market share for 2016 shipments as well as a forecast for 2017-2021.
To view a detailed description and Table of…
More Releases for Premature
Premature Labor (Tocolysis) Market Size, Share and Growth Report, 2034
Introduction
The premature labor tocolysis market addresses one of the most critical challenges in obstetrics-delaying preterm birth to improve neonatal survival and reduce complications. Tocolytic therapy involves the use of medications to suppress uterine contractions, giving physicians valuable time for administering antenatal corticosteroids or transferring patients to facilities equipped for high-risk deliveries.
The market is gaining momentum due to increasing preterm birth rates globally, better perinatal care infrastructure, and ongoing advancements in…
Premature Treatment Market Anticipates a Noteworthy CAGR of 9.9%
The premature treatment market addresses a prevalent and distressing sexual health concern that impacts a significant number of men globally. Premature (PE) is characterized by the consistent and uncontrollable that occurs shortly after or even before sexual penetration, leading to dissatisfaction and frustration for both partners. The market for premature treatment encompasses a variety of therapeutic approaches aimed at improving ejaculatory control, prolonging sexual activity, and enhancing overall sexual satisfaction.
Market…
Increasing Premature Births Boost Enteral Nutrition Market
The enteral nutrition market will touch USD 13,811.6 million, growing at a 6.2% compound annual growth rate, by 2030.
The growth of this industry is mainly because of the increasing elderly population, surging occurrence of malnutrition, and growing count of premature births, which results in rising ICU deaths.
Request for sample pages of this report: https://www.psmarketresearch.com/market-analysis/enteral-nutrition-market/report-sample
Moreover, the increasing incidence of chronic conditions like cancer, chronic liver disease, stroke, diabetes, multiple sclerosis, chronic…
Urbaser provides extra support to employees with premature babies
Environmental services company, Urbaser, has agreed to offer extra support for its UK staff who are the parents of premature babies by introducing the Smallest Things policy.
The Smallest Things campaign asks employers to provide parents of premature babies with extra leave, at full pay, to help them through what can be a very difficult time. Mothers and fathers of babies born at or before 37 weeks can have an extra…
Premature Ejacualtion Market - Global Outlook and Forecast to 2022
ReportsnReports.com adds "Premature Ejacualtion Market - Global Outlook and Forecast 2017 – 2022" report to its research store.
The report considers the present scenario of the global premature ejaculation market and its in-depth analysis for the period 2017-2022. It includes a detailed study of growth drivers, trends, and restraints. The report also profiles the leading vendors in the market and other key vendors.
Innovus Pharma, Plethora Solutions, Absorption Pharmaceuticals and Allergan are…
Premature Ejaculation Treatment Market- Insights
Ejaculation means discharging of semen from the body. Premature ejaculation (PE) also known as rapid ejaculation, premature climax or early ejaculation is a condition in which the ejaculation happens earlier than a man or his partner would like during a sexual intercourse. The main sign of PE is incapability to delay ejaculation for more than one minute after penetration. Mainly PE can be classified in two types, namely lifelong (primary)…
